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Aims: To describe the development and management of ocular hypertension (OHT) and 
secondary glaucoma (SG) in patients with juvenile idiopathic arthritis (JIA)-associated uve-
itis.
Patients and methods: A series of 104 patients with newly diagnosed JIA and associated 
uveitis was collected in 1989–1996. A re-evaluation was made after mean 9.7 years (range 
0.8–15.6 years) follow-up. OHT was diagnosed if intraocular pressure (IOP) had been 22 
mmHg for longer than 3 months or when a single IOP was 30 mmHg despite normal visual 
ﬁ  eld and optic disc. SG was diagnosed in a patient who had optic disc changes and/or visual 
ﬁ  eld defects compatible with glaucoma.
Results: OHT or SG developed in 14 patients (14%, 22 eyes). IOP was under control 
(<22 mmHg) in 2 patients without treatment and in 3 patients with medication. Filtering 
surgery was performed in 9 patients, 5 of them needed additional glaucoma medication. The 
binocular visual acuity was 0.5 or better in all patients; in ﬁ  ve eyes vision was less than 0.5, 
but no eye blinded.
Conclusion: OHT or SG in JIA patients with uveitis is a diagnostic and therapeutic challenge, 
but if the medical and surgical treatment is timed correctly, the sight can be saved in most 
patients.
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Introduction
In juvenile idiopathic arthritis (JIA) chronic insidious uveitis develops in 20% of 
patients. The prevalence of glaucoma in JIA-associated uveitis ranges from 14%–27% 
(Wolf et al 1987; Kanski 1990; Kotaniemi et al 2001, 2003).
Secondary glaucoma (SG) is one of the most common causes of blindness in 
children and young adults with chronic uveitis (Merayo-Lloves et al 1999; Foster 
et al 2000; Sijssens et al 2006). Uveitic glaucoma may be a diagnostic problem. The 
elevation of intraocular pressure (IOP) may be oscillating, transient and innocuous, 
or persistent and severely damaging. On the other hand, exacerbation of uveitis may 
cause shutdown of the ciliary body and lead to hypotony, thus masking the underlying 
glaucoma. Multiple mechanisms may be involved in the elevation of IOP; closure of 
the anterior chamber angle with or without pupil block, and mechanism of open-angle 
glaucoma. Additionally, a patient may be a steroid-responder (Melamed et al 2000; 
Allingham et al 2005).
Topical steroids and systemic immunosuppressive drugs are the mainstay of uveitis 
treatment together with the best possible management of the underlying disease. Despite Clinical Ophthalmology 2007:1(4) 456
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many kinds of glaucoma medications, a conservative treat-
ment of SG is often inadequate (Melamed et al 2000; Sung and 
Barton 2004; Allingham et al 2005). In cases of a pupillary 
block, laser iridotomy is performed. Trabeculectomy with 
or without adjunctive antimetabolites may be required in 
patients with a permanent trabecular dysfunction. Goniotomy, 
viscocanalostomy or deep sclerectomy have been performed 
in some refractory cases. Cycloablation with the diode laser, 
free running YAG laser or cycloprobe may be necessary in 
some cases of treatment-resistant glaucoma (Raivio et al 2001; 
Ceballos et al 2002; Freedman et al 2002; Quintyn et al 2003; 
Auer et al 2004; Ho et al 2004; Heinz et al 2006). However, 
in many children with chronic uveitis artiﬁ  cial ﬁ  ltering shunts 
(such as Molteno or Ahmed) work best (Molteno et al 1984; 
Välimäki et al 1997; Ozdal et al 2005).
We describe the occurrence and management of ocular 
hypertension (OHT) and SG in series of 104 children with 
JIA-associated uveitis.
Patients and methods
An observational series of 104 JIA patients with uveitis is 
described. The patients were drawn out of 426 children with 
newly diagnosed JIA during 1989–1996 at the Rheumatism 
Foundation Hospital, Heinola, Finland (Kotaniemi et al 
2001).The Rheumatism Foundation Hospital is a tertiary 
center for patients with juvenile arthritis from the whole 
country, but also serves as a secondary center for those living 
nearby. A pediatric rheumatologist had conﬁ  rmed the diag-
nosis of JIA for every patient according to the ILAR criteria 
(Petty and Southwood 1998).
The main characteristics of the patients are shown in 
Table 1. At the re-evaluation point, the mean age of the 
patients was 14.5 years (range 4.1–24.4 years), the mean 
follow-up time from the diagnosis of JIA was 9.7 years 
(range 0.8–15.6 years) and the mean duration of uveitis was 
6.9 years (range 0.1–14.9 years).
The ophthalmic examination included best corrected 
visual acuity, careful biomicroscopy of the eyes and exami-
nation of the fundus of the eye with 90 dioptre lens. The 
diagnosis of uveitis was made according to the IUSG rec-
ommendations (Bloch-Michel and Nussenblatt 1987). The 
IOP was measured by applanation tonometry, whenever 
possible. OHT was diagnosed in patients in whom the IOP 
had been 22 mmHg for longer than 3 months, or a single 
IOP was higher than 30 mmHg and glaucoma treatment had 
been initiated despite normal visual ﬁ  eld (when an examina-
tion had been possible) and optic disc. SG was diagnosed 
if a glaucomatous cupping of the optic disc was seen or a 
glaucomatous visual ﬁ  eld was detected and IOP was higher 
than 21 mmHg (Walton 1994; Merayo-Lloves et al 1999). 
Visual ﬁ  eld examinations were not possible to all our patients 
because of young age and therefore the evaluation of the 
visual ﬁ  elds was not reasonable.
Glaucoma surgery was indicated, when IOP had been 
constantly higher than 21 mmHg for longer than 3 months 
despite 2 to 4 different glaucoma drugs. The decision of 
implantation of the ﬁ  ltering device was made after dis-
cussion with 2 to 3 specialists dealing with complicating 
uveitis. Trabeculectomy with or without mitomycin-C 
and deep sclerectomy were the method of surgery in a few 
Table 1 Comparison of the characteristics of all patients with JIA-associated uveitis with those complicated with elevated IOP
  All patients with uveitis  Patients with elevated IOP  p value
Number of patients  n 104  n 14
Gender M/F  35/69  2/12  0.13
Mean age at onset of JIA, years (SD)  4.8 (3.8)  3.7 (3.5)  0.25
Mean age at onset of uveitis, years (SD)  5.9 (3.6)  3.9 (3.2)  0.026
Mean age at onset of glaucoma, years (SD)    9.8 (3.2) 
Type of JIA      0.83
-Oligoarthritis (%)  76 (66)  10 (71)
-RF negative polyarthritis (%)  25 (24)  4 (29)
-RF positive polyarthritis (%)  1 (1)  0
-Systemic onset arthritis (%)  1 (1)  0
-Enthesitis related arthritis (%)  0  0
-Psoriatic arthritis (%)  1 (1)  0
ANA+ (%)  69 (66)  11 (79)  0.37
HLA B27+ (%)  20/74 (27)  2/9 (22)  0.81
Abbreviations: JIA, juvenile idiopathic arthritis; SD, standard deviation; RF, rheumatoid factor;   ANA, antinuclear antibodies; HLA, human leukocyte antigen; IOP, intraocular 
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cases. In the most refractory cases cyclodestruction was 
made (Molteno et al 1984; Välimäki et al 1997; Raivio et al 
2001; Quintyn et al 2003; Ho et al 2004; Sung et Barton 
2004; Heinz et al 2006).
Results
Fifty-four out of the 104 patients with JIA-associated 
uveitis (52%) had ongoing insidious uveitis after the mean 
follow-up of 9.7 years. OHT or SG had developed in 14/104 
patients (13.5%, 22 eyes) in mean 5.8 years (range 0–11.3) 
after the uveitis had been diagnosed. All of them still had 
active uveitis. The patients who developed OHT or SG 
were younger at the onset of uveitis than those who had not 
had elevated IOP (p = 0.026) (Table 1). The use of the dis-
ease modifying antirheumatic drugs of the glaucoma/OHT 
patients at last visit is shown in Table 2.
Table 3 shows the details of the ocular status and the 
management of the patients with elevated IOP. Elevated IOP 
had been detected in both eyes of 8 patients and in either eye 
in 6 patients (Table 3, patients 2, 6, 7, 11, 13 and 14).
In 3 eyes of 2 patients a glaucomatous excavation of 
the optic nerve head and respective visual ﬁ  eld defects 
were seen and SG was diagnosed. Twelve patients had 
OHT and glaucoma treatment had been initiated because of 
their continuously high IOP values (>21 mmHg). In all the 
patients the OHT/SG was open angle type and no one had 
pupillary block. Because of the young age of the patients, 
the gonioscopy was rarely possible to perform.
In two patients the elevated IOP had normalized with 
watchful waiting during the follow up and no treatment 
was needed. In 3 patients IOP was controlled with medical 
treatment. Filtering surgery was performed in 9 patients 
because of constantly high IOP (>21 mmHg) despite 
maximal medical treatment: Molteno ﬁ  ltering device in 7 
(in one patient twice), trabeculectomy without Mitomycin 
in 1 patient and with Mitomycin in both eyes in 1 patient. 
In spite of that, glaucoma medication was needed in 5 of 
the 9 patients after surgery. None of them was a cortico-
steroid responder.
In the re-evaluation examination IOP was assessed 
to be under control (<22 mmHg) in all but 3 eyes (Table 
3). Binocular visual acuity was at least 0.5 in all patients, 
in ﬁ  ve eyes visual acuity ended up between 0.1 and 0.4. 
Impairment of the visual acuity was due to cystoid macular 
edema (2 eyes), retinal detachment (1 eye) and a secondary 
opaciﬁ  cation of posterior capsule after IOL implantation 
(1 eye). In one eye (patient 4, Table 3) a corneal trans-
plantation was performed after implantation of the second 
Molteno and the ﬁ  ltering devices were removed; the visual 
acuity was 0.2.
Discussion
Uveitic glaucoma in childhood is a diagnostic and therapeu-
tic challenge. We have followed our series of 104 patients 
from the very beginning of arthritis and uveitis for nearly 
10 years, on the average. Initially, we did not speciﬁ  cally 
look after the development of elevated IOP and that is 
why the data are in some degree deﬁ  cient. On the other 
hand, frequently the ophthalmologic examination of small 
children is challenging and examination of visual ﬁ  elds or 
chamber angle is not possible. In our series of patients the 
diagnosis of OHT or SG was mostly based on constantly 
high IOP values and the treatment had to be initiated before 
the SG criteria were fulﬁ  lled.
Recently, Sijssens and colleagues (2006) reported that 
38% of their 24 patients with JIA-associated uveitis had 
developed secondary glaucoma after 5 years. The interval 
between the diagnosis of uveitis and elevation of ocular pres-
sure was only 1 year. Neri and colleagues (2004) detected 
glaucoma in 11% of their uveitis patients after 5 years fol-
low-up. In our observational series 26% (14/54) of those with 
ongoing uveitis developed OHT/SG. However, the median 
length of time from uveitis to glaucoma in our series was 
markedly longer, 5.8 years. The majority of the children in 
our series were seen by the same ophthalmologists every 1–3 
months from the very beginning of uveitis and thus their uve-
itis was diagnosed at an early stage. The patients were care-
fully monitored and the treatment of uveitis and arthritis was 
Table 2 Disease modifying antirheumatic drugs of the glaucoma/
ocular hypertension patients alone or in combination at the last 
visit
Antirheumatic Number  of  patients




-Cyclosporin A  6
-Azathioprine 2
-Leﬂ  unomide  3
-Prednisolon 10
Biologic drugs 
-Etanercept   4
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constantly changed according to the activity of both arthritis 
and uveitis. The elevated IOP was frequently detected before 
glaucomatous changes had developed in the eye.
According to Välimäki and colleagues (1997), the best treat-
ment of uncontrolled secondary glaucoma in JIA- associated 
uveitis is implantation of the molteno filtering device, 
because the failure rate after trabeculectomy in JIA children 
was known to be high and the use of mitomycin in child-
hood was inconvenient. In our series the control of IOP 
was achieved by Molteno ﬁ  ltering device in 7 of the 14 
patients. However, 5 of the patients who had been operated 
on, needed additional glaucoma medication. In one case, 
after the Molteno tube had been reimplantated, the cornea 
decompensated leading to removal of the ﬁ  ltering devices 
and to corneal transplantation. The effect of Molteno tube 
may be decreased by postoperative ﬁ  brosis causing a need 
of glaucoma medication.
In a large cohort of uveitis patients reported by 
Merayo-Lloves and colleagues (1999), 16% of the patients 
with JIA-associated uveitis ended up with chronic second-
ary glaucoma during the 10-year follow-up. Their choice 
of treatment was Mitomycin-C trabeculectomy or insertion 
of a drainage implant in patients with refractory glaucoma. 
Inadequate control of glaucoma was found in 9% of their 
JIA patients with uveitis despite aggressive treatment 
of uveitis and SG. The frequency of SG in the series of 
Merayo-Lloves and colleagues corresponds to that of ours: 
14% of patients with JIA-associated uveitis developed OHT 
or SG. Also a great majority of our patients underwent 
ﬁ  ltering surgery.
In our series all the 14 patients with elevated IOP had bin-
ocular visual acuity >0.5, whereas 42% of the uveitis patients 
of Merayo-Lloves and 64% of the uveitis cases of Neri had 
visual acuity >0.5 after 5 years follow-up. The difference 
may be due to different patient series.Even if techniques of 
the modern glaucoma surgery have improved the progno-
sis of this severe disease, we still have treatment resistant 
cases. We agree with Merayo-Lloves and colleagues (1999) 
that by early recognition of uveitis and active treatment of 
uveitis and underlying arthritis, development of secondary 
glaucoma can be diminished. In this observational series of 
JIA patients with associated uveitis, drainage shunt implan-
tation was frequently the choice of treatment of elevated 
intraocular pressure.
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